Key facts
- This page summarizes Saumya Sutaria's Form 4 filing for TENET HEALTHCARE CORP (THC).
- 8 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 03 Mar 2026, 20:01.
Saumya Sutaria - 27 Feb 2026 Form 4 Insider Report for TENET HEALTHCARE CORP (THC)
- Reporting relationship
- CEO, Director
- Issuer ticker
- THC
- Reported as of
- 27 Feb 2026
- Net transaction value
- -$39,281,462
- SEC form
- 4
- Accepted by SEC
- 03 Mar 2026, 20:01:03 UTC
- Prior SEC filing
- 26 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- Chad J. Wiener, as Attorney-in-fact for Saumya Sutaria
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Saumya Sutaria filed Form 4 for TENET HEALTHCARE CORP (THC) on 03 Mar 2026.
Change
- Previous filing in this sequence was filed on 26 Feb 2026.
- Current net transaction value: -$39,281,462.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001760857
Primary reporting owner
Sutaria Saumya
- Relationship
- CEO, Director
- Address
- 14201 DALLAS PARKWAY, DALLAS
- Signature
- Chad J. Wiener, as Attorney-in-fact for Saumya Sutaria
- Signature date
- 03 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
THC
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +22,417
- Change %
- +3.5%
- Price
- Shares after
- 661,340
- Date
- 27 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
THC
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +36,384
- Change %
- +5.5%
- Price
- Shares after
- 697,724
- Date
- 27 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
THC
transaction
Common Stock
Tax liability
- Transaction value
- $2,205,218
- Shares
- -9,282
- Change %
- -1.3%
- Price
- $237.58
- Shares after
- 688,442
- Date
- 27 Feb 2026
- Ownership
- Direct
- Footnotes
- F2, F3
THC
transaction
Common Stock
Tax liability
- Transaction value
- $7,162,309
- Shares
- -29,919
- Change %
- -4.3%
- Price
- $239.39
- Shares after
- 658,523
- Date
- 27 Feb 2026
- Ownership
- Direct
- Footnotes
- F4, F5
THC
transaction
Common Stock
Tax liability
- Transaction value
- $29,913,935
- Shares
- -124,959
- Change %
- -19%
- Price
- $239.39
- Shares after
- 533,564
- Date
- 27 Feb 2026
- Ownership
- Direct
- Footnotes
- F2, F5
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
THC
transaction
Derivative
2026 February Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +36,092
- Change %
- Price
- $0.000000
- Shares after
- 36,092
- Date
- 27 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 36,092
- Exercise price
- Footnotes
- F6
THC
transaction
Derivative
2024 February Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -22,417
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 22,417
- Date
- 27 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 22,417
- Exercise price
- Footnotes
- F7, F8
THC
transaction
Derivative
2023 March Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -36,384
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 27 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 36,384
- Exercise price
- Footnotes
- F8, F9
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 9 footnotes
Footnote F1
Restricted stock units convert into common stock on a one-for-one basis.
Footnote F2
Reflects shares delivered by reporting person to satisfy withholding taxes due upon vesting of performance share units.
Footnote F3
Represents the closing price of the common stock of the Issuer on the vesting date for the award.
Footnote F4
Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
Footnote F5
Represents the closing price of the common stock of the Issuer on February 27, 2026.
Footnote F6
These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting.
Footnote F7
The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 28, 2024, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment vested on February 27, 2026 (the business day prior to February 28, 2026, which fell on a weekend).
Footnote F8
Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.
Footnote F9
The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third 1/3 increment vested on February 27, 2026 (the business day prior to March 1, 2026, which fell on a weekend).